News from NYU Langone Health

Family Health Centers Receive $600k Grant To Expand Anti-Overdose Education Programs In Brooklyn. (Brooklyn (NY) Paper)

The Brooklyn (NY) Paper (9/4) The Sunset Park Health Council, including nine Brooklyn-based Family Health Centers at NYU Langone Health, has received a $600,000 grant from the Anthem Blue Cross and Blue Shield Foundation to expand its anti-overdose education program across Brooklyn over the next three years through the Prevention Education Partnership program, which focuses on opioid use, overdose prevention, and harm reduction for teachers, students, and schools; Diana S. Lee, MD, assistant medical director, Addiction Medicine Program Family Health Centers at NYU Langone Health, and clinical assistant professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, said, “All of us at the Family Health Centers at NYU Langone Health are thrilled to receive this grant and expand the overdose prevention program to make a greater impact for the youth in the Sunset Park community.”

Also reporting were News 12 Brooklyn (USA) (9/4).

NYU Langone Study Helps Explain Link Between World Trade Center Dust And Breast Cancer. (Crain's New York Business)

Paywalled* Crain’s New York Business (9/5) A study led by Alan A. Arslan, associate professor, Departments of Obstetrics and Gynecology, and Population Health, found that women exposed to World Trade Center dust were almost four times more likely to exhibit hypermethylation, a genetic process linked to tumor growth suppression disruption, with Arslan noting, “The dust contained hundreds or even thousands of known or suspected carcinogens, including asbestos, arsenic, cadmium, PCBs and others, many of which were known to affect DNA methylation”; the study, funded by a $250,000 grant from the CDC and NIOSH, provides a new objective method to assess exposure levels.

NYU Langone Health Resource Fair Raises Over $125,000 To Distribute Over 2,800 Backpacks Of School Supplies. (NY1-TV New York)

NY1-TV (9/4) In Brooklyn, a resource fair by the Family Health Centers at NYU Langone Health raised over $125,000 to distribute and fund more than 2,800 backpacks filled with school supplies, while also offering health screenings; Larry K. McReynolds, clinical associate professor, Department of Population Health, Family Health Centers, executive director, said, “It makes me feel wonderful because I get to see that moms have that stress relieved.”

NYU Langone Unveils On-Demand Primary Care. (Becker's Hospital Review)

Becker’s Hospital Review (9/4) NYU Langone Health has introduced walk-in primary care services at two new “Care on Demand” locations in Manhattan’s West Village and Upper East Side, allowing new and existing patients to receive care for common health issues without an appointment; “NYU Langone Care on Demand offers a new opportunity for people to access our system’s exceptional quality, in the moment and without an appointment,” said Robert I. Grossman, MD, dean and CEO.

Also reporting is Upper East Side (NY) Patch (9/4).

The Weight Loss Drug That Can Prevent Diabetes. (TIME)

TIME (9/4) Eli Lilly reported that its longest study on tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss, showed a 94% reduction in the risk of prediabetes progressing to diabetes compared to a placebo; Michael A. Weintraub, MD, clinical assistant professor, Department of Medicine, Division of Endocrinology, Diabetes, & Metabolism, noted that such a drug could enable earlier intervention for at-risk patients, saying, “We don’t have any medication approved to treat prediabetes right now.”

Dr Sabari On The FDA Approval Of Amivantamab/Lazertinib In EGFR+ Advanced NSCLC. (OncLive)

OncLive (9/4) Joshua K. Sabari, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, discusses the FDA approval of amivantamab-vmjw (Rybrevant) plus lazertinib (Leclaza) in EGFR-mutated advanced non-small cell lung cancer (NSCLC), concluding that the deeper and more sustained responses seen with this regimen could translate into meaningful clinical benefit, offering patients a longer duration of disease control and potentially improving quality of life.

How Physicians Feel About Their Workplace Culture, Charted. (Advisory Board Company)

Advisory Board Company (9/4) Priya Jaisinghani, MD, clinical assistant professor, Department of Medicine, Division of Endocrinology, Diabetes, & Metabolism, negotiated a 4-day workweek to prioritize work-life balance when she took her first job out of fellowship in 2022, saying, “I was able to prioritize work-life balance from the start”; she also appreciated the mentorship, access to trainees, and autonomy provided by NYU Langone Health, adding, “After dedicating so many years to medical training, you want to look for some degree of autonomy in building your practice.”

Gabriela Hearst, Sabrina Dhowre Elba, Jane Lauder And More Women Leaders To Speak At WWD X FN X Beauty Inc Women In Power. (Women's Wear Daily)

Women’s Wear Daily (9/4) Women leaders across fashion, beauty, retail, and more will gather at the 1 Hotel in Brooklyn for “Women in Power: Up to the Challenge”, a daylong event from WWD, Footwear News, and Beauty Inc., where discussions will cover innovation, brand building, empowerment, design, and work culture, with additional speakers including Elizabeth Comen, MD, associate professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center.

Kidney Donors’ Risk Of Death At All-Time Low. (ReachMD)

ReachMD (9/4) Analyzing three decades of medical records representing 164,593 kidney donors nationwide, a team led by researchers at NYU Langone Health found that by 2022, fewer than one death occurred for every 10,000 donations, translating to 36 deaths in total over 30 years. “While we had always understood that kidney donation is safe, our findings suggest that mortality among donors is extremely rare, and the procedure is safer than ever before,” said Allan B. Massie, PhD, associate professor, Departments of Surgery, and Population Health. “These results demonstrate that the current guidelines used to inform potential kidney donors of their risks need to be updated to reflect nearly a decade of safety improvements,” said Dorry L. Segev, MD, PhD, professor, Department of Surgery, Division of Transplant Surgery, professor, Department of Population Health, vice chair for research, Department of Surgery and the Surgical Sciences. “As a kidney donor and research scientist in the field, it is reassuring to see the progress we have made,” said Macey L. Levan, JD, PhD, associate professor, Department of Surgery, Division of Transplant Surgery, and Department of Population Health.

The Wellness Industry: Financially Toxic, Says Ethicist. (Internal Medicine)

Internal Medicine (9/4)* Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, criticized the wellness industry for driving up healthcare costs without providing evidence of efficacy, stating, “Wellness interventions, whether it’s transcranial magnetism or all manner of supplements that are sold in health food stores, over and over again, we see a world in which wellness is promoted but no data are introduced to show that any of it helps, works, or does anybody any good.”

Also reporting is Cardiology News (9/4).

False-Positive Mammogram Results Discourage Future Screenings. (NBC)

NBC’s Today (9/3) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, discusses the findings of researchers in a new study on mammograms, which found that false-positive results could affect a woman’s likelihood to return for future screenings and prevent successful detection of cancer.

News from NYU Langone Hospital—Brooklyn

The 5 Warning Signs Of Deadly Stroke That Strike Up To 90 Days Before. (US Sun)

The US Sun (9/4) Brandon Giglio, MD, clinical assistant professor, Department of Neurology, NYU Langone Hospital—Brooklyn, told the Huffington Post that a transient ischemic attack (TIA) often precedes a full-blown stroke, a serious condition where the brain’s blood supply is interrupted, within days or weeks, stating, “It really is a harbinger in many people for someone who is going to have a stroke even within the next 48 hours and certainly within the next seven, 30, 90 days.”